Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Nepal Health Res Counc ; 22(1): 108-113, 2024 Jun 22.
Artículo en Inglés | MEDLINE | ID: mdl-39080946

RESUMEN

BACKGROUND: A series of acute, atypical respiratory diseases was identified in Wuhan, China, which was named Coronavirus disease (COVID-19) by the World Health Organization (WHO), and the disease was later declared a pandemic. This disease has psychological effects in addition to physiological symptoms. This study aims to find out the psychological impacts of disease in the form of anxiety and depressive symptoms among hospitalized patients diagnosed with COVID-19. METHODS: A multicentric descriptive cross-sectional study was conducted among patients diagnosed with COVID-19 who were admitted from July 1, 2021 to August 15, 2021 in six different hospitals. Ethical approval was obtained from the Nepal Health Research Council (reference number 284). COVID-19 was diagnosed using Reverse Transcription Polymerase Chain Reaction (RT-PCR) or COVID-19 antigen test. Data were collected from the patients using proforma containing the demographic profile and two questionnaires (Hospital Anxiety and Depression scale and Global Health Questionnaire-12) translated into the Nepali language. RESULTS: Among 360 patients who participated in the study, 194 (53.9%) were males and 166 (46%) were females. Symptoms of anxiety and depression were seen in 161 (44.7%) and 253 (70.3%) of the participants respectively. Similarly 349 (96.9%) of them were found to have clinically significant mental distress. CONCLUSIONS: The prevalence of anxiety and depressive symptoms among hospitalized patients diagnosed with COVID-19 is significantly high compared to the general population.


Asunto(s)
Ansiedad , COVID-19 , Depresión , Hospitalización , SARS-CoV-2 , Humanos , COVID-19/epidemiología , COVID-19/psicología , Femenino , Masculino , Nepal/epidemiología , Estudios Transversales , Persona de Mediana Edad , Prevalencia , Adulto , Depresión/epidemiología , Ansiedad/epidemiología , Hospitalización/estadística & datos numéricos , Anciano , Adulto Joven , Adolescente
2.
JNMA J Nepal Med Assoc ; 61(264): 662-664, 2023 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-38289815

RESUMEN

Pyrexia of unknown origin refers to a fever of over 38.3°C on multiple occasions for at least three weeks without a known aetiology, even after a week of hospitalization. Adult-onset Still's disease is a rare systemic auto-inflammatory disorder with a prevalence of 0.6/100,000 population characterized by spiking fever, arthralgia or arthritis and maculopapular rash. Here, we present a case of 19 years-old female with pyrexia of unknown origin. With no identifiable cause and fulfilled criteria of Yamaguchi, a diagnosis of adult-onset Still's disease was made. She was treated with Intravenous steroid therapy followed by oral steroids and non-steroidal anti-inflammatory drugs. This case highlights the awareness of the possible adult-onset Still's disease patients with pyrexia of unknown origin. However, one should remain cautious and exclude all other differentials before making this diagnosis, as the actual disease may masquerade as adult-onset Still's disease criteria. Keywords: arthralgia; case reports; fever.


Asunto(s)
Artritis , Enfermedad de Still del Adulto , Adulto , Humanos , Femenino , Adulto Joven , Enfermedad de Still del Adulto/complicaciones , Enfermedad de Still del Adulto/diagnóstico , Enfermedad de Still del Adulto/tratamiento farmacológico , Antiinflamatorios no Esteroideos/uso terapéutico , Fiebre/etiología , Artritis/tratamiento farmacológico , Artralgia/complicaciones , Artralgia/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA